NMT1 Antibodies

Santa Cruz Biotechnology offers a broad range of NMT1 monoclonal antibodies for various research applications. NMT1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NMT1, or N-myristoyltransferase 1, plays a crucial role in the post-translational modification of proteins, specifically by adding a myristoyl group to glycine residues. This modification is essential for the proper localization and function of many signaling proteins, influencing cellular processes such as growth, differentiation, and apoptosis. Given its involvement in various cellular pathways, NMT1 is a significant target for understanding disease mechanisms and developing therapeutic strategies. NMT1 has been extensively studied in cancer research, where its activity has been linked to tumor progression and metastasis. Research has also shown that NMT1 plays important roles in cardiovascular diseases and inflammatory responses. Understanding NMT1's function in different biological processes continues to reveal new insights into disease pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of NMT1's role in health and disease.